Concepedia

Lester A. Dolak

LA

Statistics

Publications

34

Citations

1.7K

H-Index

22

Active since

1966

Affiliations

W.E. Upjohn Institute for Employment Research(Current)

Pfizer (United States)

Lester A. Dolak is an author at W.E. Upjohn Institute for Employment Research specializing in medicinal chemistry, drug discovery, and pharmacology.

Publications per year

1966–2008

34

Publications

34

Tipranavir (PNU-140690):  A Potent, Orally Bioavailable Nonpeptidic HIV Protease Inhibitor of the 5,6-Dihydro-4-hydroxy-2-pyrone Sulfonamide Class

Steve R. Turner, Joseph W. Strohbach, Rubén Tommasi et al. · Journal of Medicinal Chemistry · 1998 · 296 citations · Full text

, , +17

Structure-Based Design of Novel HIV Protease Inhibitors: Carboxamide-Containing 4-Hydroxycoumarins and 4-Hydroxy-2-pyrones as Potent Nonpeptidic Inhibitors

Suvit Thaisrivongs, Keith David Watenpaugh, W. Jeffrey Howe et al. · Journal of Medicinal Chemistry · 1995 · 121 citations · Full text

, , +11

Structure-Based Design of HIV Protease Inhibitors:  Sulfonamide-Containing 5,6-Dihydro-4-hydroxy-2-pyrones as Non-Peptidic Inhibitors

Suvit Thaisrivongs, Harvey I. Skulnick, Steve R. Turner et al. · Journal of Medicinal Chemistry · 1996 · 96 citations · Full text

, , +12

Design, synthesis, structure–activity relationship, and in vivo activity of azabicyclic aryl amides as α7 nicotinic acetylcholine receptor agonists

Daniel P. Walker, Donn G. Wishka, David W. Piotrowski et al. · Bioorganic & Medicinal Chemistry · 2006 · 94 citations

, , +17

Identification of Phenylisoxazolines as Novel and Viable Antibacterial Agents Active against Gram-Positive Pathogens

Michael R. Barbachyn, Gary J. Cleek, Lester A. Dolak et al. · Journal of Medicinal Chemistry · 2002 · 90 citations

, , +14

1–5 of 34